SynthesisESMO open2024

Immune checkpoint inhibitors in advanced gastroesophageal adenocarcinoma: a series of patient-level meta-analyses in different programmed death-ligand 1 subgroups.

A G Leone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.